AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
VISCERAL VARICELLA-ZOSTER AFTER BONE-MARROW TRANSPLANTATION - REPORT OF A CASE SERIES AND REVIEW OF THE LITERATURE
Authors: DAVID DS TEGTMEIER BR ODONNELL MR PAZ IB MCCARTY TM
Citation: Ds. David et al., VISCERAL VARICELLA-ZOSTER AFTER BONE-MARROW TRANSPLANTATION - REPORT OF A CASE SERIES AND REVIEW OF THE LITERATURE, The American journal of gastroenterology, 93(5), 1998, pp. 810-813
CYTOGENETICS PREDICT COMPLETE REMISSION RATE (CR) FOR ADULT PATIENTS WITH DE-NOVO ACUTE MYELOGENOUS LEUKEMIA (AML) TREATED WITH HIGH-DOSE CYTARABINE (HD ARA-C)
Authors: STEIN A ODONNELL MR SLOVAK ML LEE J NADEMANEE A PARKER P SNYDER D SMITH E MOLINA A SOMLO G MARGOLIN K FAHEY J BIERMAN P STEPAN D NILAND J BLUME KG FORMAN SJ
Citation: A. Stein et al., CYTOGENETICS PREDICT COMPLETE REMISSION RATE (CR) FOR ADULT PATIENTS WITH DE-NOVO ACUTE MYELOGENOUS LEUKEMIA (AML) TREATED WITH HIGH-DOSE CYTARABINE (HD ARA-C), Blood, 90(10), 1997, pp. 277-277
ALLOGENEIC (ALLO) AND MATCHED UNRELATED DONOR (MUD) BONE-MARROW TRANSPLANTATION (BMT) IN 46 PATIENTS GREATER-THAN 50 YEARS OF AGE
Authors: KASHYAP A PARKER P NADEMANEE A FUNG H MOLINA A BHATIA R KRISHNAN A ODONNELL MR PLANAS I SNYDER DS SPIELBERGER R STEIN A LEE J FORMAN SJ
Citation: A. Kashyap et al., ALLOGENEIC (ALLO) AND MATCHED UNRELATED DONOR (MUD) BONE-MARROW TRANSPLANTATION (BMT) IN 46 PATIENTS GREATER-THAN 50 YEARS OF AGE, Blood, 90(10), 1997, pp. 468-468
HIGH-DOSE THERAPY AND AUTOLOGOUS STEM TRANSPLANTATION (ASCT) AS CONSOLIDATION THERAPY DURING FIRST COMPLETE REMISSION (CR) OR PARTIAL REMISSION (PR) IN PATIENTS WITH UNFAVORABLE PROGNOSIS AND ADVANCED-STAGE HODGKINS-DISEASE (HD)
Authors: NADEMANEE A MOLINA A STEIN A PLANAS I FUNG H DAGIS A ODONNELL MR SNYDER DS PARKER P SPIELBERGER R KASHYAP A BHATIA R KRISHNAN A SNIECINSKI K VORA N FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM TRANSPLANTATION (ASCT) AS CONSOLIDATION THERAPY DURING FIRST COMPLETE REMISSION (CR) OR PARTIAL REMISSION (PR) IN PATIENTS WITH UNFAVORABLE PROGNOSIS AND ADVANCED-STAGE HODGKINS-DISEASE (HD), Blood, 90(10), 1997, pp. 495-495
PHASE-2 STUDY OF INTERLEUKIN-2 (IL-2) FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT) FOR ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR)
Authors: STEIN A ODONNELL MR LEE J BHATIA R FUNG H KASHYAP A KRISHNAN A NADEMANEE A MOLINA A MARGOLIN K PARKER P PLANAS I SPIELBERGER R SNYDER D SMITH E SOMLO G SLOVAK ML VORA N SNIECINSKI I NILAND J FORMAN SJ
Citation: A. Stein et al., PHASE-2 STUDY OF INTERLEUKIN-2 (IL-2) FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT) FOR ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR), Blood, 90(10), 1997, pp. 1699-1699
A PROSPECTIVE RANDOMIZED TRIAL COMPARING CYCLOSPORINE-A AND PREDNISONE (CSA PSE) VERSUS CYCLOSPORINE-A, METHOTREXATE AND PREDNISONE (CSA/MTX/PSE) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE - EFFECT ON CHRONIC GRAFT-VERSUS-HOST DISEASE AND LONG-TERM SURVIVAL/
Authors: ROSS M FORMAN SJ WONG RM SCHMIDT GM NILAND JC AMYLON MD DAGIS AC LONG GD NADEMANEE AP NEGRIN RS ODONNELL MR PARKER PM SMITH EP SYNDER DS STEIN AS BLUME KG CHAO NJ
Citation: M. Ross et al., A PROSPECTIVE RANDOMIZED TRIAL COMPARING CYCLOSPORINE-A AND PREDNISONE (CSA PSE) VERSUS CYCLOSPORINE-A, METHOTREXATE AND PREDNISONE (CSA/MTX/PSE) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE - EFFECT ON CHRONIC GRAFT-VERSUS-HOST DISEASE AND LONG-TERM SURVIVAL/, Blood, 90(10), 1997, pp. 2624-2624
RESULTS OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION DURING REMISSION IN POOR-RISK INTERMEDIATE-GRADE AND HIGH-GRADE LYMPHOMA - INTERNATIONAL INDEX HIGH AND HIGH-INTERMEDIATE RISK GROUP
Authors: NADEMANEE A MOLINA A ODONNELL MR DAGIS A SNYDER DS PARKER P STEIN A SMITH E PLANAS I KASHYAP A SPIELBERGER R FUNG H WONG KK SOMLO G MARGOLIN K CHOW W SNIECINSKI I VORA N BLUME KG NILAND J FORMAN SJ
Citation: A. Nademanee et al., RESULTS OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION DURING REMISSION IN POOR-RISK INTERMEDIATE-GRADE AND HIGH-GRADE LYMPHOMA - INTERNATIONAL INDEX HIGH AND HIGH-INTERMEDIATE RISK GROUP, Blood, 90(10), 1997, pp. 3844-3852
IN-VIVO PURGING WITH HIGH-DOSE CYTARABINE FOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND REINFUSION OF UNPURGED BONE-MARROW FOR ADULT ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: STEIN AS ODONNELL MR CHAI A SCHMIDT GM NADEMANEE A PARKER PM SMITH EP SNYDER DS MOLINA A STEPAN DE SPIELBERGER R SOMLO G MARGOLIN KA VORA N LIPSETT J LEE J NILAND J FORMAN SJ
Citation: As. Stein et al., IN-VIVO PURGING WITH HIGH-DOSE CYTARABINE FOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND REINFUSION OF UNPURGED BONE-MARROW FOR ADULT ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION, Journal of clinical oncology, 14(8), 1996, pp. 2206-2216
POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER P CHAO NJ BENEZRA J SLATKIN N OPENSHAW H NILAND JC LINKER CA GREFFE BS KASHYAP A MOLINA A NADEMANEE A ODONNELL MR PLANAS I SHEIBANI K SMITH EP SNYDER DS SPIELBERGER R STEIN AS STEPAN DE BLUME KG FORMAN SJ
Citation: P. Parker et al., POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Medicine, 75(5), 1996, pp. 279-285
TREATMENT OF PERIANAL INFECTION FOLLOWING BONE-MARROW TRANSPLANTATION
Authors: COHEN JS PAZ IB ODONNELL MR ELLENHORN JDI
Citation: Js. Cohen et al., TREATMENT OF PERIANAL INFECTION FOLLOWING BONE-MARROW TRANSPLANTATION, Diseases of the colon & rectum, 39(9), 1996, pp. 981-985
HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/
Authors: MOLINA A NADEMANEE A ODONNELL MR SNYDER DS STEIN AS PARKER PM SMITH EP LEE J PLANAS I KASHYAP A SPIELBERGER RT MARGOLIN K SOMLO G KAPOOR N CHOW W VORA N SNIECINSKI I NILAND J FORMAN SJ
Citation: A. Molina et al., HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/, Blood, 88(10), 1996, pp. 472-472
DO CYTOGENETICS PREDICT OUTCOME OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 1ST REMISSION (CR)
Authors: STEIN AS ODONNELL MR SLOVAK M LEE J KASHYAP A MOLINA A NADEMANEE A PARKER P PLANAS I SNYDER DS SPIELBERGER R SOMLO G MARGOLIN K NILAND J FORMAN SJ
Citation: As. Stein et al., DO CYTOGENETICS PREDICT OUTCOME OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 1ST REMISSION (CR), Blood, 88(10), 1996, pp. 1928-1928
ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH INCURABLE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS (LGLPD)
Authors: MOLINA A PARKER P STEIN AS SPIELBERGER R NADEMANEE A SNYDER DS ODONNELL MR SMITH EP MARGOLIN K DAGIS A PLANAS I KASHYAP A SOMLO G KAPOOR N VORA N NILAND J FORMAN SJ
Citation: A. Molina et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH INCURABLE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS (LGLPD), Blood, 88(10), 1996, pp. 2465-2465
FATAL SCEDOSPORIUM-PROLIFICANS (SCEDOSPORIUM-INFLATUM) FUNGEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - REPORT OF A CASE IN THE UNITED-STATES
Authors: SPIELBERGER RT TEGTMEIER BR ODONNELL MR ITO JI
Citation: Rt. Spielberger et al., FATAL SCEDOSPORIUM-PROLIFICANS (SCEDOSPORIUM-INFLATUM) FUNGEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - REPORT OF A CASE IN THE UNITED-STATES, Clinical infectious diseases, 21(4), 1995, pp. 1067-1067
BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/
Authors: ODONNELL MR LONG GD PARKER PM NILAND J NADEMANEE A AMYLON M CHAO N NEGRIN RS SCHMIDT GM SLOVAK ML SMITH EP SNYDER DS STEIN AS TRAWEEK T BLUME KG FORMAN SJ
Citation: Mr. Odonnell et al., BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/, Journal of clinical oncology, 13(12), 1995, pp. 2973-2979
THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER PM CHAO N NADEMANEE A ODONNELL MR SCHMIDT GM SNYDER DS STEIN AS SMITH EP MOLINA A STEPAN DE KASHYAP A PLANAS I SPIELBERGER R SOMLO G MARGOLIN K ZWINGENBERGER K WILSMAN K NEGRIN RS LONG GD NILAND JC BLUME KG FORMAN SJ
Citation: Pm. Parker et al., THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 86(9), 1995, pp. 3604-3609
IDARUBICIN (IDA) AND HIGH-DOSE CYTOSINE-ARABINOSIDE (HD ARA-C) FOR INDUCTION THERAPY FOR AML AND AML ARISING FROM MYELODYSPLASIA (MDS AML)/
Authors: STEIN AS ODONNELL MR NADEMANEE A PARKER P LEE J MOLINA A KASHYAP A SPIELBERGER R SMITH E PLANAS I SNYDER D SOMLO G MARGOLIN K NILAND J FORMAN SJ
Citation: As. Stein et al., IDARUBICIN (IDA) AND HIGH-DOSE CYTOSINE-ARABINOSIDE (HD ARA-C) FOR INDUCTION THERAPY FOR AML AND AML ARISING FROM MYELODYSPLASIA (MDS AML)/, Blood, 86(10), 1995, pp. 2046-2046
HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS/
Authors: NADEMANEE A ODONNELL MR SNYDER DS SCHMIDT GM PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE SOMLO G MARGOLIN KA SNIECINSKI I DAGIS AC NILAND J PEZNER R FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 85(5), 1995, pp. 1381-1390
PREDICTION OF SYSTEMIC FUNGAL INFECTION IN ALLOGENEIC MARROW RECIPIENTS - IMPACT OF AMPHOTERICIN PROPHYLAXIS IN HIGH-RISK PATIENTS
Authors: ODONNELL MR SCHMIDT GM TEGTMEIER BR FAUCETT C FAHEY JL ITO J NADEMANEE A NILAND J PARKER P SMITH EP SNYDER DS STEIN AS BLUME KG FORMAN SJ
Citation: Mr. Odonnell et al., PREDICTION OF SYSTEMIC FUNGAL INFECTION IN ALLOGENEIC MARROW RECIPIENTS - IMPACT OF AMPHOTERICIN PROPHYLAXIS IN HIGH-RISK PATIENTS, Journal of clinical oncology, 12(4), 1994, pp. 827-834
HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA USING UNPRIMED AND GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS
Authors: NADEMANEE A SNIECINSKI I SCHMIDT GM DAGIS AC ODONNELL MR SNYDER DS PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE SOMLO G MARGOLIN KA WOO D NILAND JC FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA USING UNPRIMED AND GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical oncology, 12(10), 1994, pp. 2176-2186
FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: SNYDER DS NEGRIN RS ODONNELL MR CHAO NJ AMYLON MD LONG GD NADEMANEE AP STEIN AS PARKER PM SMITH EP SOMLO G MARGOLIN K MOLINA A STEPAN DE LIPSETT JA HOPPE RT SLOVAK ML NILAND JC DAGIS AC WONG RM FORMAN SJ BLUME KG
Citation: Ds. Snyder et al., FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 84(5), 1994, pp. 1672-1679
USE OF PREEMPTIVE GANCICLOVIR BASED SOLELY ON ASYMPTOMATIC PULMONARY CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS - LONG-TERM FOLLOW-UP
Authors: ZAIA JA SCHMIDT GM CHAO NJ RIZK N NADEMANEE AP NILAND JC HORAK DA LEE J GALLEZHAWKINS G KUSNIERZGLAZ CR ODONNELL MR PARKER PM SNYDER DS SMITH EP STEIN A MOLINA A STEPAN D BLUME KG FORMAN SJ
Citation: Ja. Zaia et al., USE OF PREEMPTIVE GANCICLOVIR BASED SOLELY ON ASYMPTOMATIC PULMONARY CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS - LONG-TERM FOLLOW-UP, Blood, 84(10), 1994, pp. 10000249-10000249
EXTRACORPOREAL PHOTOCHEMOTHERAPY (EP) FOR TREATMENT OF DRUG-RESISTANTGRAFT-VERSUS-HOST DISEASE (GVHD)
Authors: SMITH E SNIECINSKI I PARKER PM MOLINA A NADEMANEE A ODONNELL MR SNYDER DS STEIN A STEPAN DE FORMAN SJ
Citation: E. Smith et al., EXTRACORPOREAL PHOTOCHEMOTHERAPY (EP) FOR TREATMENT OF DRUG-RESISTANTGRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 84(10), 1994, pp. 10000332-10000332
NEUTROPENIA IS A COMPLICATION OF THALIDOMIDE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER PM NADEMANEE A ODONNELL MR SNYDER DS STEIN A SMITH E MOLINA A STEPAN DE CHAO N NILAND JC BLUME KG FORMAN SJ
Citation: Pm. Parker et al., NEUTROPENIA IS A COMPLICATION OF THALIDOMIDE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 84(10), 1994, pp. 10000335-10000335
COCCIDIOIDOMYCOSIS IN BONE-MARROW TRANSPLANT RECIPIENTS
Authors: RILEY DK GALGIANI JN ODONNELL MR ITO JI BEATTY PG EVANS TG
Citation: Dk. Riley et al., COCCIDIOIDOMYCOSIS IN BONE-MARROW TRANSPLANT RECIPIENTS, Transplantation, 56(6), 1993, pp. 1531-1533
Risultati: 1-25 | 26-32